PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.

Mol Pharm · 2014 · PMC4123940 · PMID 24987803

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendP = 0.09so close (0.05 < p ≤ 0.1)

Furthermore, PTX formulated in PEG 5K -FTS 4 showed a trend of improvement in antitumor activity compared with PTX formulated in PEG 5K -FTS 2 ( P = 0.09).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.